Imo although it was not on abstract, something else that would be interesting to know from the LL and other drug mOS and survivng patient percentages per year, is if those were taking into account what the official cause of death was--was it from cancer or another pre-existing condition or a new one (such as the patient got pneumonia or covid). If the cause of death was from another condition or disease, could that mean from the cancer treatment aspect that those rates are higher because the cancer progression was being handled and was not the cause of death?

Imo